Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: Fluorescence-based selection of transduced cells

Blood

Volumn 94, Issue 2, 1999, Pages 465-474

  Fontanelles, Antonio ^b   Mazurier, Frédéric ^b   Moreau Gaudry, François ^b   Belloc, Francis ^b   Ged, Cécile ^b   De Verneuil, Hubert ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PORPHYRIN; UROPORPHYRINOGEN DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL SELECTION; CONTROLLED STUDY; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS; FLUORESCENCE; GENE THERAPY; HEPATOERYTHROPOIETIC PORPHYRIA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL; RETROVIRUS; ULTRAVIOLET RADIATION;

EID: 0033566284     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.465.414k14_465_474     Document Type: Article

References (35)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y: The porphyrias, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease, vol 2. New York, NY, Mc Graw Hill, 1995, p 2103
2. de Verneuil H, Grandchamp B, Nordmann Y: Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochim Biophys Acta 611:174, 1980
3. de Verneuil H, Sassa S, Kappas A: Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphy-rinogens I and III. J Biol Chem 4:2454, 1983
4. Moran-Jimenez MJ, Ged C, Romana M, Enriquez De Salamanca R, Taieb A, Topi G, D'Alessandro L, de Verneuil H: Uroporphyrinogen decarboxylase: Complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet 58:712, 1996
5. 281 → Glu) in a case of porphyria. Science 234:732, 1986
6. Roberts AG, Elder GH, Enriquez de Salamanca R, Herrero C, Lecha M, Mascaro J: A mutation (G281 E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: Biochemical and genetic studies on Spanish patients. J Invest Dermatol 104:500, 1995
7. Nolta A, Kohn D: Haematopoietic stem cells for gene therapy, in Potten CS (ed): Stem Cells. London, UK, Academic, 1997, p 447
8. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
9. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460, 1988
10. Landau NR, Littman DR: Packaging system for rapid production of murine leukemia virus vectors with a variable tropism. J Virol 66:5110, 1992
11. Lim CK, Peters TJ: Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Chim Acta 139:55, 1984
12. Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474, 1993
13. Cannon MJ, Pisa P, Fox RI, Cooper NR: Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 85:1333, 1990
14. Sharara LI, Andersson A, Guy-Grand D, Fisher A, Di Santo JP: Deregulated TCRαβT cell population provokes extramedullary hematopoiesis in mice deficient in the common γ chain. Eur J Immunol 27:990, 1997
15. Princ FG, Juknat AA, Maxit AG, Cardalda C, Batlle A: Melatonin's antioxidant protection against delta-aminolevulinic acid-induced oxidative damage in rat cerebellum. J Pineal Res 23:40, 1997
16. Moreau-Gaudry F, Mazurier F, Bensidhoum M, Ged C, de Verneuil H: Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines. Blood 85:1449, 1995
17. Moreau-Gaudry F, Barbot C, Mazurier F, Mahon FX, Reiffers, Ged C, de Verneuil H: Correction of the enzyme deficit of bone marrow cells in congenital erythropoietic porphyria by retroviral gene transfer. Hematol Cell Ther 38:217, 1996
18. Mazurier F, Moreau-Gaudry F, Salesse S, Barbot C, Ged C, Reiffers J, de Verneuil H: Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. J Inherit Metab Dis 20:247, 1997
19. Moreau-Gaudry F, Ged C, de Verneuil H: Gene therapy for erythropoietic porphyrias. Gene Ther 3:843, 1996
20. Stewart K, Brown OA, Morelli AE, Fairbairn LJ, Lashford LS, Cooper A, Hatton CE, Dexter TM, Castro MG, Lowenstein PR: Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro. Gene Ther 4:63, 1997
21. Braun SE, Aronovich EL, Anderson RA, Crotty PL, McIvor RS, Whitley CB: Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase. Proc Natl Acad Sci USA 90:11830, 1993
22. Taylor RM, Wolfe JH: Cross-correction of beta-glucuronidase deficiency by retroviral vector-mediated gene transfer. Exp Cell Res 214:606, 1994
23. Taylor RM, Wolfe JH: Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase. Nat Med 3:771, 1997
24. Moullier P, Bohl D, Cardoso J, Heard JM, Danos O: Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs. Nat Med 1:353, 1995
25. Sangalli A, Taveggia C, Salviati A, Wrabetz L, Bordignon C, Severini GM: Transduced fibroblasts and metachromatic leukodystrophy lymphocytes transfer arylsulfatase A to myelinating glia and deficient cells in vitro. Hum Gene Ther 9:2111, 1998
26. Hershfield MS: PEG-ADA replacement therapy for adenosine deaminase deficiency: An update after 8.5 years. Clin Immunol Immunopathol 76:S228, 1995
27. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF: T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270:475, 1995
28. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
29. Hoogerbrugge PM, von Beusechem VW, Kaptein LC, Einerhand MP, Valerio D: Gene therapy for adenosine deaminase deficiency. Br Med Bull 51:72, 1995
30. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
31. Fenjves ES, Schwartz PM, Blaese RM, Taichman LB: Keratinocyte gene therapy for adenosine deaminase deficiency: A model approach for inherited metabolic disorders. Hum Gene Ther 8:911, 1997
32. Morgan WT, Smith A, Kostelo P: The interaction of human serum albumin and hemopexin with porphyrins. Biochim Biophys Acta 624:271, 1980
33. Koningsberger JC, Rademakers LHPM, van Hattum J, Baart de la Faille H, Wiegman LJJM, Italiaander E, van Berge Henegouwen GP, Marx JJM: Exogenous protoporphyrin inhibits Hep G2 cell proliferation, increases the intracellular hydrogen peroxide concentration and causes ultrastructural alterations. J Hepatol 22:57, 1995
34. Van Steveninck J, Boegheim JPJ, Dubbelman TMAR, Van der Zee J: The mechanism of potentiation of horseradish peroxidase-catalysed of NADPH by porphyrins. Biochem J 242:611, 1987
35. Van Steveninck J, Boegheim JPJ, Dubbelman TMAR, Van der Zee J: The influence of porphyrins on iron-catalysed generation of hydroxyl radicals. Biochem J 250:197, 1988